Research is needed on the difficult-to-cure population of hepatitis C virus patients with disability.
Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD.
Viktor
V
Chirikov
Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD.
Fadia
F
Shaya
Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD.
C
C
Mullins
Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD.
Susan
S
dosReis
Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD.
Eberechukwu
E
Onukwugha
Department of Medicine, Howard University Hospital, Washington, DC.
Charles
C
Howell
D000998:Antiviral Agents; D016174:Hepacivirus; D019698:Hepatitis C, Chronic; D006801:Humans
D000998:Antiviral Agents